Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$10,083,969
+$2,045,974 QoQ
Shares Held
40,073
+8.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#914
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $48,413,418 across 14 Drug Manufacturers - General names. ABBV ranks #2 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,543 | $12,645,591 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
40,073 | $10,083,969 | |
| 3 | JNJ |
Johnson & Johnson
|
27,094 | $6,881,063 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
46,311 | $5,850,931 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
94,459 | $5,442,727 | |
| 6 | AMGN |
Amgen Inc
|
7,107 | $2,573,586 | |
| 7 | MRK |
Merck & Co., Inc.
|
14,481 | $1,860,808 | |
| 8 | NVS |
Novartis AG
|
11,132 | $1,744,607 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,083,969 | 40,073 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $8,037,995 | 36,958 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $8,499,142 | 37,197 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $8,485,941 | 36,650 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $7,294,680 | 39,299 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $10,259,565 | 48,967 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $5,670,229 | 31,909 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $6,361,818 | 32,215 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,048,005 | 29,431 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $5,411,283 | 29,716 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $4,735,728 | 30,559 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $5,206,367 | 34,928 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $4,916,701 | 36,493 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,419,695 | 34,007 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $6,241,216 | 38,619 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $5,552,133 | 41,369 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,868,882 | 57,906 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $9,475,977 | 58,454 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,486,330 | 62,676 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $7,753,264 | 71,876 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $8,023,572 | 71,232 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $9,028,145 | 83,424 | Shares | Sole | 2021-06-17 | |
| 2020-12-31 | $8,766,048 | 81,811 | Shares | Sole | 2021-05-19 | |
| 2020-09-30 | $4,919,755 | 56,168 | Shares | Sole | 2021-09-07 | |
| 2020-06-30 | $5,940,675 | 60,508 | Shares | Sole | 2021-09-07 | |
| 2020-03-31 | $4,271,820 | 56,068 | Shares | Sole | 2021-09-07 | |
| No filing history on record for this holder in this stock. | ||||||